Burst technology expands treatment options for patients suffering from chronic  pain and provides significant relief so they can reclaim their quality of  life,” says Dirk De Ridder, neurological professor of Neurosurgery, from the  University of Otago in Dunedin, New Zealand. “Prodigy’s pioneering stimulation  mode allows me to tune therapy to my patient’s unique pain condition. Burst  holds promise to fill the void where alternative stimulation modes fail to  control patients’ pain or for those who lose therapeutic benefit over time.”

St Jude Medical’s new burst technology offers intermittent “bursts” of stimulation designed to provide an alternative therapy method for chronic  conditions such as back pain. In addition, burst stimulation has been  demonstrated to minimise paraesthesia in some patients which can often  fluctuate with posture and body position changes. Early evidence suggests that  by enabling the delivery of both modes of stimulation, clinicians can more  effectively adjust therapy to address the patient’s unique pain condition.

The Prodigy system features the longest-lasting battery life, even at the  highest settings, of any rechargeable spinal cord stimulation device in its  class. Additionally, its small size allows for a smaller incision, which gives  physicians increased flexibility in selecting the implant location and is  intended to make the site less visible and more comfortable for patients.

Through an Investigational Device Exemption from the US Food and Drug Administration (FDA), the St. Jude Medical study called SUNBURST (Success using  neuromodulation with burst) is evaluating whether burst stimulation can be more  effective in managing chronic pain than traditional tonic stimulation.

(source: Neuronews)


INVITO PER PARTECIPARE ALLA SURVEY NAZIONALE SULL'UTILIZZO DELLA STIMOLAZIONE BURST CON IL SISTEMA DI NEUROMODULAZIONE PRODIGYTM


(clicca sull'immagine per visualizzare il documento)


 LETTERA DI INCARICO

(clicca sull'immagine per visualizzare il documento)


 

 

 

Copyright © 2017. INS Neuromodulazione - Capitolo Italiano All Rights Reserved.